Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

NGM 313

Next Previous
Drug Profile

NGM 313

Alternative Names: MK 3655; NGM-313

Latest Information Update: 25 Dec 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator NGM Biopharmaceuticals
  • Developer Merck & Co; NGM Biopharmaceuticals
  • Class Antihyperglycaemics; Hepatoprotectants; Monoclonal antibodies; Obesity therapies
  • Mechanism of Action KLB protein stimulants; Type 1 fibroblast growth factor receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Non-alcoholic steatohepatitis
  • Discontinued Non-alcoholic fatty liver disease; Obesity

Most Recent Events

  • 19 Dec 2024 NGM-313 licensed to KdT Ventures worldwide
  • 19 Dec 2024 KdT Ventures' new company plans a phase-II proof-of-concept trial in the year 2025
  • 20 Mar 2023 Discontinued - Phase-I for Non-alcoholic fatty liver disease in USA (SC) (NGM Biopharmaceuticals pipeline, March 2023)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top